Article
Serial passaging in vitro generates a Vero cell-adapted coxsackievirus A6 strain with distinct phenotypic characteristics.
Frontiers in cellular and infection microbiology - 1 Jan 2026
Xia Sijin, Shu Rongyu, Sun Yihao, Wu Jiahui, Wang Mengjun, Du Yaxin, Yang Dongsheng, Guo Jing, Zhang Bo, Shen Shuo
Abstract excerpt
Background: Coxsackievirus A6 (CVA6) has emerged as a major etiological agent of hand, foot, and mouth disease (HFMD), yet no commercial vaccine is available against CVA6. CVA6 exhibits poor adaptability to Vero cells, a WHO-approved substrate for human vaccine production, and the mechanisms underlying its infectivity and pathogenesis remain incompletely understood. Methods: A Vero cell-adapted CVA6 strain was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
